IL95867A0 - - Google Patents

Info

Publication number
IL95867A0
IL95867A0 IL95867A IL9586790A IL95867A0 IL 95867 A0 IL95867 A0 IL 95867A0 IL 95867 A IL95867 A IL 95867A IL 9586790 A IL9586790 A IL 9586790A IL 95867 A0 IL95867 A0 IL 95867A0
Authority
IL
Israel
Prior art keywords
live virus
subject
neutralizing
antibody
producing
Prior art date
Application number
IL95867A
Other languages
English (en)
Other versions
IL95867A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IL95867A0 publication Critical patent/IL95867A0/xx
Publication of IL95867A publication Critical patent/IL95867A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL9586790A 1989-10-02 1990-10-02 Attached vaccines for active vaccine production IL95867A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41603589A 1989-10-02 1989-10-02
US48067890A 1990-02-15 1990-02-15
US58685990A 1990-09-24 1990-09-24

Publications (2)

Publication Number Publication Date
IL95867A0 true IL95867A0 (fr) 1991-07-18
IL95867A IL95867A (en) 1994-10-07

Family

ID=27411077

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9586790A IL95867A (en) 1989-10-02 1990-10-02 Attached vaccines for active vaccine production

Country Status (11)

Country Link
US (4) US5397569A (fr)
EP (2) EP0755684B1 (fr)
AT (2) ATE200735T1 (fr)
AU (2) AU6714290A (fr)
BR (1) BR9007702A (fr)
CA (1) CA2066661C (fr)
DE (2) DE69033728T2 (fr)
DK (2) DK0755684T3 (fr)
ES (2) ES2102368T3 (fr)
IL (1) IL95867A (fr)
WO (1) WO1991004749A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104382A0 (en) * 1992-01-17 1993-05-13 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
AU715555B2 (en) 1996-09-30 2000-02-03 University Of Arkansas, The Method of producing active immunity with vaccine conjugate
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
JP5209160B2 (ja) * 1999-08-24 2013-06-12 エービーアイシー・バイオロジカル・ラボラトリーズ・リミテッド ワクチン組成物およびその使用方法
US6682754B2 (en) * 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US20030170823A1 (en) 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
EP1161953A3 (fr) * 2000-06-09 2004-02-04 Akzo Nobel N.V. Souche d'IBDV pour l'administration in ovo
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
US7029681B2 (en) 2002-03-08 2006-04-18 Schweitzer Chemical Corporation Multiple and multivalent DNA vaccines in ovo
US7037506B2 (en) 2002-03-08 2006-05-02 Schweltzer Chemical Corporation Ltd. Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
CA2480163A1 (fr) 2002-03-22 2003-10-09 Zymogenetics, Inc. Anticorps anti-il-tif et leurs methodes d'utilisation dans une inflammation
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
WO2006082588A2 (fr) * 2005-02-07 2006-08-10 Pharmalight Inc. Procede et dispositif d'administration ophtalmique d'ingredients pharmaceutiquement actifs
WO2008147847A1 (fr) * 2007-05-22 2008-12-04 Baylor College Of Medicine Vaccination à base de complexes immuns en tant que stratégie permettant de renforcer l'immunité des personnes âgées et d'autres populations immunocompromises
WO2013158217A1 (fr) 2012-04-20 2013-10-24 Thomas Jefferson University Anticorps modifié destiné à l'inhibition de fibrose
WO2014110092A1 (fr) * 2013-01-08 2014-07-17 Humabs Biomed Sa Procédés de génération de réponses immunitaires passive robuste et active
CN103341164B (zh) * 2013-07-19 2015-06-24 天津瑞普生物技术股份有限公司 一种鸡传染性法氏囊病抗原抗体复合物、制剂及制备方法
CA3153379A1 (fr) 2019-09-11 2021-03-18 Zoetis Services Llc Vecteurs recombinants du virus de l'herpes de la dinde exprimant des antigenes de pathogenes aviaires et utilisations associees

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2518978A (en) * 1946-09-12 1950-08-15 American Cyanamid Co Hog cholera vaccine
DE1041214B (de) * 1957-03-11 1958-10-16 Dr Med Karl Theurer Verfahren zur Herstellung von Impfstoffen gegen Viruserkrankungen
US3846543A (en) * 1963-01-02 1974-11-05 Monsanto Co Process for the separation of virus from non-viral proteins
US3326767A (en) * 1966-03-21 1967-06-20 Abbott Lab Avian leukosis treatment with inactivated rous sarcoma virus
US3651213A (en) * 1969-05-29 1972-03-21 Monsanto Co Method for the immunization of a living animal body against viral disease
US3853467A (en) * 1973-08-15 1974-12-10 Gen Electric Method and apparatus for immunological detection of biological particles
CA1039649A (fr) * 1973-08-30 1978-10-03 General Electric Company Methode pour former des films d'un complexe immunologique en plusieurs couches
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
EP0073856A1 (fr) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Vaccins contre la bronchite infectieuse de la volaille, vaccins combinés contre la bronchite infectieuse, procédé de préparation de ces vaccins, procédé de prévention de la bronchite infectieuse et souche de virus de la bronchite infectieuse
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4493825A (en) * 1982-10-05 1985-01-15 Iowa State University Research Foundation Purified and antigenically selective vaccines for domestic animals
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4614793A (en) * 1983-10-14 1986-09-30 Merck & Co., Inc. Hepatitis A--subunit antigen
US4743562A (en) * 1984-08-21 1988-05-10 The Board Of Trustees Of The Leland Stanford Junior University Purified human cytomegalovirus protein
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US4956452A (en) * 1987-06-14 1990-09-11 The University Of Maryland Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5057314A (en) * 1988-09-30 1991-10-15 Whitfill Craig E Low molecular weight antiviral factors

Also Published As

Publication number Publication date
DE69033728D1 (de) 2001-05-31
DK0755684T3 (da) 2001-08-20
US6299874B1 (en) 2001-10-09
EP0755684A1 (fr) 1997-01-29
DE69030383D1 (de) 1997-05-07
ES2102368T3 (es) 1997-08-01
DK0495008T3 (da) 1997-10-13
EP0495008A1 (fr) 1992-07-22
ATE200735T1 (de) 2001-05-15
US6136319A (en) 2000-10-24
EP0495008B1 (fr) 1997-04-02
CA2066661C (fr) 2001-05-08
ES2158200T3 (es) 2001-09-01
ATE150976T1 (de) 1997-04-15
AU6755990A (en) 1991-04-28
CA2066661A1 (fr) 1991-04-03
DE69033728T2 (de) 2001-11-22
DE69030383T2 (de) 1997-10-23
WO1991004749A1 (fr) 1991-04-18
IL95867A (en) 1994-10-07
EP0755684B1 (fr) 2001-04-25
EP0495008A4 (en) 1993-05-05
AU6714290A (en) 1991-04-28
US5397569A (en) 1995-03-14
US5871748A (en) 1999-02-16
AU641958B2 (en) 1993-10-07
BR9007702A (pt) 1992-08-18

Similar Documents

Publication Publication Date Title
IL95867A0 (fr)
ES2109929T3 (es) Procedimiento para preparar un glucano de levadura
BR9713312B1 (pt) preparado de vacina para uso veterinário útil para produzir imunidade ativa contra uma doença bacteriana ou protozoária.
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
DE69030099D1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
JPS6463392A (en) Monoclonal antibody against specific antigen for human immunodeficiency virus
DE69333730D1 (de) Impfstoff, der acemannan als adjuvans enthält
NZ235474A (en) Virus capable of inducing infectious bursal disease; assay and vaccine
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
Ristau et al. Bovine leucosis virus challenge infection of calves following application of BL-3 cells
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
CS578887A1 (en) Inactivated antigen of cattle's mucosal disease's virus
Zampachova Possibilities of serological evidence of sexually transmitted infection caused by Chlamydia trachomatis.
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
CS406989A1 (en) Method of antigen production for proof of minks' aleucaemic disease's virus antibodies
HUP9902513A2 (hu) Aktív immunitás létrehozására szolgáló vakcinakonjugátumok
LV12736A (en) Method for producing concentrated antigen composition against swine erysipelas disease
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
EXP Patent expired